Lantheus Holdings, Inc. - Understand $lnth stock

$LNTH Market Cap: $6.177 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$1.497B

TTM

Gross Margin

64.78%

TTM

Net Earnings

$427.6M

TTM

Current Assets

$1.296B

Q3 2024

Current Liabilities

$784.1M

Q3 2024

Current Ratio

165.25%

Q3 2024

Total Assets

$2.050B

Q3 2024

Total Liabilities

$869.9M

Q3 2024

Book Value

$1.180B

Q3 2024

Cash

$866.4M

Q3 2024

P/E

14.44

Nov 29, 2024 EST

Free Cash Flow

$378.6M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$1.296B	$935.1M	$425.2M	$339.4M	$347.3M	$343.4M	$331.4M	$301.9M	$293.5M	$301.6M	$283.7M	$288.1M	$356.3M
YoY Change	38.65%	119.91%	25.28%	-2.28%	1.15%	3.62%	9.78%	2.86%	-2.7%	6.32%	-1.54%	-19.14%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$1.296B	$935.1M	$425.2M	$339.4M	$347.3M	$343.4M	$331.4M	$301.9M	$293.5M	$301.6M	$283.7M	$288.1M	$356.3M
Cost Of Revenue	$586.9M	$353.4M	$237.5M	$200.6M	$172.5M	$168.5M	$169.2M	$164.1M	$157.9M	$176.1M	$206.3M	$212.9M	$261.1M
Gross Profit	$709.5M	$581.7M	$187.7M	$138.8M	$174.8M	$174.9M	$162.1M	$137.8M	$135.5M	$125.5M	$77.36M	$75.20M	$95.20M
Gross Profit Margin	54.73%	62.21%	44.14%	40.88%	50.33%	50.93%	48.93%	45.64%	46.18%	41.62%	27.27%	26.1%	26.72%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Selling, General & Admin	$267.2M	$233.8M	$218.8M	$110.2M	$103.1M	$93.33M	$92.16M	$75.37M	$78.63M	$72.43M	$68.26M	$70.00M	$71.60M
YoY Change	14.27%	6.86%	98.62%	6.83%	10.51%	1.27%	22.27%	-4.15%	8.57%	6.1%	-2.48%	-2.23%
% of Gross Profit	37.66%	40.2%	116.58%	79.4%	59.0%	53.36%	56.84%	54.71%	58.02%	57.7%	88.24%	93.09%	75.21%
Research & Development	$77.71M	$311.7M	$44.97M	$32.79M	$20.02M	$17.07M	$18.13M	$12.20M	$14.36M	$13.67M	$30.46M	$40.60M	$40.90M
YoY Change	-75.07%	593.15%	37.14%	63.79%	17.26%	-5.82%	48.53%	-15.01%	5.01%	-55.11%	-24.98%	-0.73%
% of Gross Profit	10.95%	53.58%	23.96%	23.63%	11.45%	9.76%	11.18%	8.86%	10.59%	10.89%	39.37%	53.99%	42.96%
Depreciation & Amortization	$60.04M	$47.93M	$42.29M	$24.69M	$13.38M	$13.93M	$19.23M	$800.0K	$11.80M	$9.900M	$9.300M	$27.40M	$32.77M
YoY Change	25.27%	13.34%	71.28%	84.53%	-3.95%	-27.56%	2303.75%	-93.22%	19.19%	6.45%	-66.06%	-16.39%
% of Gross Profit	8.46%	8.24%	22.53%	17.79%	7.65%	7.97%	11.86%	0.58%	8.71%	7.89%	12.02%	36.44%	34.42%
Operating Expenses	$344.9M	$545.5M	$263.8M	$143.0M	$123.2M	$110.4M	$110.3M	$87.58M	$92.99M	$86.10M	$96.25M	$76.00M	$112.5M
YoY Change	-36.77%	106.8%	84.52%	16.09%	11.55%	0.1%	25.93%	-5.82%	8.0%	-10.55%	26.65%	-32.44%
Operating Profit	$364.6M	$36.20M	-$60.83M	-$4.198M	$51.66M	$64.49M	$51.85M	$56.59M	$42.53M	$39.42M	-$18.89M	-$800.0K	-$17.30M
YoY Change	907.44%	-159.51%	1348.9%	-108.13%	-19.89%	24.37%	-8.37%	33.05%	7.9%	-308.65%	2261.38%	-95.38%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Interest Expense	$20.02M	$7.185M	$7.752M	$9.479M	$13.62M	$17.41M	$18.41M	$26.62M	$38.72M	$42.29M	$42.92M	-$42.30M	-$37.50M
YoY Change	178.62%	-7.31%	-18.22%	-30.39%	-21.76%	-5.46%	-30.84%	-31.25%	-8.45%	-1.46%	-201.45%	12.8%
% of Operating Profit	5.49%	19.85%			26.36%	26.99%	35.5%	47.04%	91.03%	107.28%
Other Income/Expense, Net	$66.32M	-$1.703M	-$7.350M	$2.198M	-$6.221M	$2.465M	$8.638M	$220.0K	-$65.00K	$505.0K	$1.161M	$500.0K	$1.600M
YoY Change	-3994.3%	-76.83%	-434.39%	-135.33%	-352.37%	-71.46%	3826.36%	-438.46%	-112.87%	-56.5%	132.2%	-68.75%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Pretax Income	$410.9M	$26.72M	-$75.04M	-$11.48M	$28.63M	$49.55M	$39.64M	$28.29M	-$11.78M	-$2.366M	-$60.54M	-$42.60M	-$53.20M
YoY Change	1438.02%	-135.61%	553.7%	-140.1%	-42.22%	25.0%	40.1%	-340.23%	397.8%	-96.09%	42.12%	-19.92%
Income Tax	$84.28M	-$1.348M	-$3.759M	$1.994M	-$3.040M	$9.030M	-$83.75M	$1.532M	$2.968M	$1.195M	$1.014M	-$600.0K	$84.10M
% Of Pretax Income	20.51%	-5.05%			-10.62%	18.22%	-211.27%	5.41%
Net Earnings	$326.7M	$28.07M	-$71.28M	-$13.47M	$31.67M	$40.52M	$123.4M	$26.80M	-$14.70M	-$3.600M	-$61.60M	-$42.00M	-$137.3M
YoY Change	1063.86%	-139.38%	429.05%	-142.55%	-21.84%	-67.16%	360.39%	-282.31%	308.33%	-94.16%	46.67%	-69.41%
Net Earnings / Revenue	25.2%	3.0%	-16.76%	-3.97%	9.12%	11.8%	37.23%	8.88%	-5.01%	-1.19%	-21.72%	-14.58%	-38.53%
Basic Earnings Per Share	$4.79	$0.41	-$1.06	-$0.25	$0.81	$1.06	$3.31	$0.84	-$0.60	-$0.20
Diluted Earnings Per Share	$4.65	$0.40	-$1.06	-$0.25	$0.79	$1.03	$3.17	$0.82	-$0.60	-$0.20	-$2.333M	-$1.591M	-$5.201M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash & Short-Term Investments	$713.7M	$415.7M	$98.51M	$79.60M	$92.90M	$113.4M	$76.30M	$51.20M	$28.60M	$19.70M	$18.60M	$33.30M
YoY Change	71.7%	321.95%	23.75%	-14.32%	-18.08%	48.62%	49.02%	79.02%	45.18%	5.91%	-44.14%
Cash & Equivalents	$713.7M	$415.7M	$98.51M	$79.60M	$92.90M	$113.4M	$76.30M	$51.20M	$28.60M	$19.70M	$18.60M	$33.30M
Short-Term Investments
Other Short-Term Assets	$23.84M	$13.09M	$12.82M	$14.90M	$7.300M	$5.200M	$5.200M	$5.200M	$8.500M	$4.400M	$3.100M	$3.100M
YoY Change	82.11%	2.14%	-13.97%	104.11%	40.38%	0.0%	0.0%	-38.82%	93.18%	41.94%	0.0%
Inventory	$64.03M	$35.48M	$35.13M	$35.70M	$29.20M	$33.00M	$26.10M	$17.60M	$15.60M	$15.60M	$18.30M	$18.00M
Prepaid Expenses
Receivables	$284.3M	$213.4M	$89.34M	$54.00M	$43.50M	$43.80M	$40.30M	$36.80M	$37.30M	$41.50M	$38.90M	$41.40M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$300.0K	$700.0K
Total Short-Term Assets	$1.086B	$677.6M	$235.8M	$184.2M	$172.9M	$195.4M	$147.9M	$110.8M	$90.00M	$81.20M	$79.20M	$96.50M
YoY Change	60.24%	187.38%	28.01%	6.54%	-11.51%	32.12%	33.48%	23.11%	10.84%	2.53%	-17.93%
Property, Plant & Equipment	$192.0M	$141.2M	$125.6M	$138.6M	$117.4M	$107.9M	$93.00M	$94.20M	$86.50M	$96.00M	$97.70M	$109.6M
YoY Change	35.99%	12.46%	-9.41%	18.06%	8.8%	16.02%	-1.27%	8.9%	-9.9%	-1.74%	-10.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.1M	$126.0M	$92.73M	$112.3M	$92.50M	$111.7M	$115.5M	$20.10M	$20.50M	$20.60M	$32.20M	$33.80M
YoY Change	27.12%	35.84%	-17.42%	21.41%	-17.19%	-3.29%	474.63%	-1.95%	-0.49%	-36.02%	-4.73%
Total Long-Term Assets	$565.3M	$643.6M	$628.0M	$685.6M	$233.0M	$244.4M	$236.0M	$145.1M	$152.4M	$162.0M	$182.1M	$228.2M
YoY Change	-12.17%	2.49%	-8.4%	194.25%	-4.66%	3.56%	62.65%	-4.79%	-5.93%	-11.04%	-20.2%
Total Assets	$1.651B	$1.321B	$863.8M	$869.8M	$405.9M	$439.8M	$383.9M	$255.9M	$242.4M	$243.2M	$261.3M	$324.7M
YoY Change
Accounts Payable	$41.19M	$20.56M	$20.79M	$16.30M	$18.60M	$18.00M	$17.50M	$18.90M	$11.70M	$15.70M	$18.10M	$18.90M
YoY Change	100.31%	-1.08%	27.53%	-12.37%	3.33%	2.86%	-7.41%	61.54%	-25.48%	-13.26%	-4.23%
Accrued Expenses	$132.1M	$203.4M	$54.31M	$36.80M	$37.40M	$32.10M	$26.50M	$21.20M	$18.50M	$24.90M	$25.50M	$29.70M
YoY Change	-35.08%	274.56%	47.59%	-1.6%	16.51%	21.13%	25.0%	14.59%	-25.7%	-2.35%	-14.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$8.000M	$8.000M	$0.00
YoY Change									-100.0%	0.0%
Long-Term Debt Due	$823.0K	$354.0K	$11.64M	$20.70M	$10.10M	$2.800M	$2.800M	$3.700M	$3.700M
YoY Change	132.49%	-96.96%	-43.76%	104.95%	260.71%	0.0%	-24.32%	0.0%
Total Short-Term Liabilities	$187.4M	$247.7M	$90.50M	$80.50M	$66.10M	$52.80M	$46.80M	$43.80M	$35.50M	$48.50M	$55.60M	$56.10M
YoY Change	-24.36%	173.71%	12.42%	21.79%	25.19%	12.82%	6.85%	23.38%	-26.8%	-12.77%	-0.89%
Long-Term Debt	$561.7M	$557.7M	$163.1M	$197.7M	$183.9M	$263.7M	$265.4M	$274.5M	$349.9M	$392.9M	$399.0M	$398.8M
YoY Change	0.71%	241.9%	-17.49%	7.5%	-30.26%	-0.64%	-3.32%	-21.55%	-10.94%	-1.53%	0.05%
Other Long-Term Liabilities	$86.24M	$68.70M	$145.7M	$77.40M	$41.30M	$52.40M	$48.40M	$44.10M	$42.30M	$41.00M	$42.10M	$42.40M
YoY Change	25.53%	-52.86%	88.28%	87.41%	-21.18%	8.26%	9.75%	4.26%	3.17%	-2.61%	-0.71%
Total Long-Term Liabilities	$647.9M	$626.4M	$308.8M	$275.1M	$225.2M	$316.1M	$313.8M	$318.6M	$392.2M	$433.9M	$441.1M	$441.2M
YoY Change	3.43%	102.82%	12.27%	22.16%	-28.76%	0.73%	-1.51%	-18.77%	-9.61%	-1.63%	-0.02%
Total Liabilities	$835.3M	$874.1M	$399.3M	$355.6M	$291.3M	$368.8M	$360.6M	$362.4M	$427.7M	$482.4M	$496.8M	$497.8M
YoY Change	-4.44%	118.89%	12.3%	22.07%	-21.01%	2.27%	-0.5%	-15.27%	-11.34%	-2.9%	-0.2%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Basic Shares Outstanding	68.27M shares	68.49M shares	67.49M shares	54.13M shares	38.99M shares	38.23M shares	37.28M shares	32.04M shares	24.44M shares	18.08M shares
Diluted Shares Outstanding	70.24M shares	70.67M shares	67.49M shares	54.13M shares	40.11M shares	39.50M shares	38.89M shares	32.66M shares	24.44M shares	18.08M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $6.1768 Billion

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2015-06-25. The firm classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.

Industry: In Vitro & In Vivo Diagnostic Substances Peers: ALIGN TECHNOLOGY INC COOPER COMPANIES, INC. QuidelOrtho Corp DENTSPLY SIRONA Inc. HAEMONETICS CORP ICU MEDICAL INC/DE NEOGEN CORP STAAR SURGICAL CO